🩺 Record Detail
Patient Info
Name: Unknown
Age: Unknown
Date: 2026-08-18 21:38:30
Transcript
[SYSTEM INSTRUCTION: If the transcript explicitly states 'The clinical notes are' (or similar), you MUST use ONLY that explicitly dictated content to fully fill out the clinical note sections. Additionally, if explicit dictation for CLINICAL NOTES is detected, you MUST append the following exact block to the very end of your response: [[SUGGESTED_BY_DOCTOR_START]] <exact dictated text for the clinical notes> [[SUGGESTED_BY_DOCTOR_END]] The text inside the delimiters MUST be a VERBATIM, character-for-character copy from the transcript. Do NOT fix typos, do NOT reformat, and do NOT correct medical terms. Do NOT output 'Suggested by Doctor:' in the main text. Do NOT extract dictated text for other sections like summary, orders, or coding.] [TRANSCRIPT] ENCOUNTER ID: longitudinal_v1 (Visit 1 of 3) SPECIALTY: Neurology PATIENT Name: Demo Patient L1 Age: 45 Sex: F Status: New patient VISIT Date: 2026-04-10 Type: In-person Location: US clinic Reason for visit: New diagnosis — chronic migraine, discussing CGRP inhibitor therapy PAYER Type: Private Plan: Demo PPO Gold Region: US CLINICAL SUMMARY Initial diagnosis of chronic migraine. Starting CGRP inhibitor. Prior authorization submitted and approved. SYSTEM MEMORY STATE No prior history — this is the baseline visit that establishes patient context and payer approval on file. EXPECTED WORKFLOW TRIGGERS - Clinical note generation - Medical coding (ICD-10 / CPT) - Prior authorization: CGRP inhibitor — APPROVED - Follow-up scheduling in 6 weeks
Clinical Notes
SOAP Clinical Note
Subjective
The patient, Demo Patient L1, a 45-year-old female, is a new patient presenting with a new diagnosis of chronic migraine. The reason for the visit is to discuss CGRP inhibitor therapy.
Objective
The consultation took place on 2026-04-10 at the US clinic. This is the baseline visit establishing the patient context and payer approval on file.
Assessment
Initial diagnosis of chronic migraine. The patient is being considered for CGRP inhibitor therapy.
Plan
Starting CGRP inhibitor therapy. Prior authorization has been submitted and approved. A follow-up is scheduled in 6 weeks.